Enhanced Humans

BioViva CEO On Becoming the First Gene Therapy Test Subject

January 24th 2016

“If you could do one action that might save a thousand, a million or a billion people—but you might die from doing it? Why would you take the risk?”

Elizabeth Parrish, the 44-year old Ceo of BioViva would. In fact, she’s claiming that recently became the world’s first gene therapy test subject. This video is a trailer for an upcoming interview where she discusses the implications of becmoing “Patient Zero.”

Copyright ©, Futurism, LLC All Rights Reserved. See our User Agreement, Privacy Policy and Cookie Statement. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission of Futurism. Fonts by Typekit and Monotype.